Evidence map›Paper›PMID 35857907›Full record

ArticleOpen biology2022

Developing immortal cell lines from

Gary J Gorbsky, John R Daum, Hem Sapkota, Katja Summala, Hitoshi Yoshida, Constantin Georgescu, Jonathan D Wren, Leonid Peshkin, Marko E Horb

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Gary J GorbskyCell Cycle and Cancer Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.ORCID 0000-0003-3076-4725
John R DaumCell Cycle and Cancer Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Hem SapkotaCell Cycle and Cancer Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Katja SummalaCell Cycle and Cancer Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Hitoshi YoshidaNational Xenopus Resource and Eugene Bell Center for Regeneration Biology and Tissue Engineering, Marine Biological Laboratory, Woods Hole, MA, USA.
Constantin GeorgescuGenes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Jonathan D WrenGenes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Leonid PeshkinNational Xenopus Resource and Eugene Bell Center for Regeneration Biology and Tissue Engineering, Marine Biological Laboratory, Woods Hole, MA, USA.
Marko E HorbNational Xenopus Resource and Eugene Bell Center for Regeneration Biology and Tissue Engineering, Marine Biological Laboratory, Woods Hole, MA, USA.
Oklahoma Medical Research Foundation · USMarine Biological Laboratory · US

Funding

Resource CoreP40OD010997 · OD · MARINE BIOLOGICAL LABORATORY · PI Marko E Horb · 2012 to 2026
$13.1M
Systems Analysis of cell type differentiation in Xenopus developmentR01HD073104 · NICHD · HARVARD MEDICAL SCHOOL · PI KIRSCHNER, MARC WALLACE, PESHKIN, LEON · 2012 to 2022
$6.7M
Xenopus Mutant ResourceR24OD030008 · OD · MARINE BIOLOGICAL LABORATORY · PI Marko E Horb · 2020 to 2026
$6.0M
NICHD NIH HHS R01 HD073104NIH HHS P40 OD010997NIH HHS R24 OD030008
6 · The paper itself

Abstract

The diploid anuran

Indexed as

ChromosomesAnimalsCell LineXenopusXenopus laevisanuracell cloningcell linedevelopmentembryoXenopus

Identifiers

PMID35857907
PMCPMC9256088
OpenAlexW4284692601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.